Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Canada House Wellness Group Announces Six-Month Extension to the Term of Warrants Issued on March 13, 2015


Posted on: 16 Mar 18

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES
OR DISSEMINATION IN THE UNITED STATES

TORONTO, March 16, 2018 (GLOBE NEWSWIRE) -- Canada House Wellness Group Inc. (CSE:CHV) (“Canada House” or the “Company”) announces that it has extended the expiry date in respect of 5,187,723 common share purchase warrants originally issued by the Company as a part of its 2015 reverse take-over transaction (the “2015 Warrants”). The 2015 Warrants were to expire on March 13, 2018. With the agreement to extend the term of the 2015 Warrants by six months, the 2015 Warrants will now expire on September 13, 2018 at 5:00 p.m. (EDT).

In connection with the agreement to extend the expiry date of the 2015 Warrants, the Company requested an exemption from section 7.4 of Policy 6 of the Canadian Securities Exchange (the “CSE”). The CSE granted the request.

All other terms and conditions of the 2015 Warrants remain unchanged. As a result of a share consolidation by the Company subsequent to the date of issuance of the 2015 Warrants, 1.5 Warrants plus payment of the exercise price of $0.375 are required to receive one common share of the Company.

The Company will deliver a notice reflecting the amended expiry date to the registered holders of the 2015 Warrants.

This news release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities described herein, and these securities will not be offered or sold in any jurisdiction in which their offer or sale would be unlawful. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the “1933 Act”), or any state securities laws of the United States. Accordingly, these securities will not be offered or sold to persons within the United States unless an exemption from the registration requirements of the 1933 Act and applicable state securities laws is available.

About Canada House Wellness Group Inc.:
Canada House is the parent company of Marijuana for Trauma Inc., Knalysis Technologies and Abba Medix Corp. The Company's goal is to become a marketplace leader through strategic partnerships, mergers, and acquisitions to create a fully integrated cannabis therapy company. For more information please visit http://www.canadahouse.ca. or www.sedar.com

For further information, please contact:
Boom Capital Markets
Steve Low
647-620-5101
steve@boomcapitalmarkets.com

Canada House Wellness Group, Inc.
Larry Bortles
1-844-696-3349
lbortles@canadahouse.ca

Cautionary Statement Regarding ForwardLooking Information. Certain statements within this news release pertaining to the Company constitute “forwardlooking statements”, within the meaning of applicable securities laws, including without limitation, statements regarding future estimates, business plans and/or objectives, sales programs, forecasts and projections, assumptions, expectations, and/or beliefs of future performance, are “forwardlooking statements”. Such “forwardlooking statements” involve known and unknown risks and uncertainties that could cause actual and future events to differ materially from those anticipated in such statements. Forwardlooking statements include, but are not limited to, statements with respect to the anticipated effects of the financing, regulatory changes, timeliness of government approvals for the granting of permits and licenses, changes in medical marijuana prices, actual operating performance of facilities, competition and other risks affecting the Company in particular and the medical marijuana industry generally, including those set out in the Company’s public disclosure record. The Company assumes no responsibility to update or revise forwardlooking information to reflect new events or circumstances unless required by law.

Neither the CSE nor its Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.

GlobeNewswire
globenewswire.com

Last updated on: 19/03/2018

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.